re: Ann: FDA agrees on potential regulatory p... Still going ahead as planned.
Taken from today's announcement:
ChemGenex is continuing its discussions with the FDA?s Center for Devices and Radiological Health towards approval of a diagnostic test for the T315I mutation, and the existing NDA for T315I positive CML patients who have failed imatinib remains open.
Ann: FDA agrees on potential regulatory pathway f, page-8
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)